Novel oral antiviral COVID-19
treatment candidate
Research carried out at Uppsala University and SciLifeLab. Financed by SciLifeLab/KAW National COVID-19 Research Program.
News
- CoLD Therapeutics will be present at the BIO International Convention in Boston on June 5-8, 2023!Please contact us if you are interested in our COVID-19 Mpro inhibitor program.
- CoLD Therapeutics will be present at the BIO International Convention in San Diego June 13-16, 2022!Please contact us if you are interested in our COVID-19 Mpro inhibitor program.
Let’s work together
Seeking partner with proven development competence by 4Q22.